BD (Becton, Dickinson and Company): BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: ...

Blue Earth Therapeutics Limited: First Patients in the UK Receive Doses of Blue Earth Therapeutics' Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...

Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable

Bringing a new drug from discovery to market is a grueling marathon that typically requires 10–15 years of research, testing, and regulatory approval. According to recent data, clinical development ...

Embrace Pet Insurance's 2025 Recap: What Luna, Mochi, and Modern Pet Trends Tell Us

Luna still leads the pack, but beyond the most popular pet names, new trends and new realities in pet care took shape in 2025 ...

Novel theranostic model shows curative potential for gastric and pancreatic tumors

A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...